Pacific Biosciences Of California (PACB) Change in Receivables (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Change in Receivables of -$6.1 million for Q1 2026, down 247.97% year-over-year from $4.1 million in Q1 2025, and down 226.2% quarter-over-quarter from $4.8 million in Q4 2025.
Pacific Biosciences Of California (PACB) Change in Receivables (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Change in Receivables history runs 17 years deep, the most recent figure standing at -$6.1 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 247.97% year-over-year to -$6.1 million; the TTM figure through Mar 2026 stood at -$2.3 million (down 273.6% YoY), while the FY2025 annual figure was $7.9 million, up 187.16% from the prior year.
- Change in Receivables for Q1 2026 stood at -$6.1 million, down from $4.8 million in the prior quarter.
- The five-year high for Change in Receivables was $10.8 million in Q1 2023, with the low at -$6.3 million in Q1 2024.
- The 5-year median for Change in Receivables is -$794000.0 (2022), against an average of $300529.4.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables slumped 1445.76% in 2022, then jumped 359.92% in 2025.
- Pacific Biosciences Of California's Change in Receivables stood at -$4.0 million in 2022, then jumped by 254.38% to $6.1 million in 2023, then plunged by 130.33% to -$1.9 million in 2024, then soared by 359.92% to $4.8 million in 2025, then tumbled by 226.2% to -$6.1 million in 2026.
- Business Quant data shows PACB's Change in Receivables at -$6.1 million in Q1 2026, $4.8 million in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | - |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Pacific Biosciences Of California | 397.64 Mn | 160.77 Mn | 12.64 Mn | 1.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Mn |
| Jun 30, 2026 | 1.75 Mn |
| Mar 31, 2026 | -6.10 Mn |
| Mar 31, 2026 | -6.10 Mn |
| Dec 31, 2025 | 4.83 Mn |
| Dec 31, 2025 | 4.83 Mn |
| Sep 30, 2025 | -1.64 Mn |
| Sep 30, 2025 | -1.64 Mn |
| Jun 30, 2025 | 612,000.00 |
| Jun 30, 2025 | 612,000.00 |
| Mar 31, 2025 | 4.12 Mn |
| Mar 31, 2025 | 4.12 Mn |
| Dec 31, 2024 | -1.86 Mn |
| Dec 31, 2024 | -1.86 Mn |
| Sep 30, 2024 | -3.05 Mn |
| Sep 30, 2024 | -3.05 Mn |
| Jun 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 2.11 Mn |
| Mar 31, 2024 | -6.29 Mn |
| Mar 31, 2024 | -6.29 Mn |